Camptosar
Showing 26 - 50 of 251
Tumors Trial (Favezelimab, Pembrolizumab, Oxaliplatin)
Active, not recruiting
- Neoplasms
- Favezelimab
- +7 more
- (no location specified)
Apr 11, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan
Withdrawn
- Metastatic Ewing Sarcoma
- Recurrent Ewing Sarcoma
- Fine-Needle Aspiration
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Metastatic Colorectal Carcinoma
- +4 more
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 4, 2022
Colorectal Tumors Trial in Pittsburgh (Bevacizumab, Oxaliplatin, Capecitabine)
Terminated
- Colorectal Neoplasms
- Bevacizumab
- +3 more
-
Pittsburgh, PennsylvaniaNSABP Operations Center
Oct 4, 2021
BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)
Active, not recruiting
- BRAF NP_004324.2:p.V600X
- +6 more
- Cetuximab
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Colorectal Cancer Trial in Park Ridge (Irinotecan, CyberKnife)
Withdrawn
- Colorectal Cancer
- Irinotecan
- CyberKnife
-
Park Ridge, IllinoisAdvocate Lutheran General Hospital
Jul 19, 2021
Pancreatic Cancer Trial in Singapore (oxaliplatin, irinotecan, capecitabine)
Completed
- Pancreatic Cancer
- oxaliplatin, irinotecan, capecitabine
-
Singapore, SingaporeNational Cancer Centre
May 28, 2021
Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)
Recruiting
- Ewing Sarcoma
- Rhabdomyosarcoma
- Olaparib
- +2 more
-
Boston, Massachusetts
- +4 more
Oct 27, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +5 more
-
Fairfield, Connecticut
- +8 more
Oct 31, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Augusta (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Irinotecan
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
- Irinotecan Injection [Camptosar]
-
Augusta, GeorgiaGeorgia Cancer Center at AU Medical Center
Jul 31, 2021
Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)
Completed
- Solid Tumors
- Primary Brain Tumors
- Vincristine
- +3 more
-
Hartford, Connecticut
- +13 more
Jan 12, 2023
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Solid Tumor, Unspecified, Adult Trial in San Francisco (Rucaparib, Irinotecan)
Completed
- Solid Tumor, Unspecified, Adult
-
San Francisco, CaliforniaUniversity of California San Francisco
Mar 2, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Pancreatic Adenocarcinoma Trial in France, United Kingdom, United States (eryaspase, Gemcitabine plus Abraxane, Irinotecan plus
Gastroesophageal Junction Adenocarcinoma, Advanced Gastric Carcinoma Trial in Edmonton (Irinotecan, Oxaliplatin, TAS 102
Not yet recruiting
- Gastroesophageal Junction Adenocarcinoma
- Advanced Gastric Carcinoma
- Irinotecan
- +2 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Mar 18, 2021
Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Magrolimab
- +4 more
-
Duarte, California
- +19 more
Jan 27, 2023
Colorectal Cancer Metastatic Trial in Guangzhou (Cetuximab, Irinotecan, Vemurafenib)
Recruiting
- Colorectal Cancer Metastatic
- Cetuximab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 7, 2021
Small Cell Lung Cancer Trial in United States (irinotecan, Carboplatin, sunitinib)
Esophageal Cancer, Gastric Cancer, Stomach Cancer Trial in Boston, Nashville, Dallas (Bevacizumab, Cisplatin, Irinotecan)
Active, not recruiting
- Esophageal Cancer
- +2 more
- Bevacizumab
- +3 more
-
Boston, Massachusetts
- +3 more
Jul 7, 2021